Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Gets $2.5M from NIH to Develop Prototype Diagnostic for Sepsis, Pneumonia

NEW YORK, Aug. 1 (GenomeWeb News) - Nanogen has received a $2.5 million grant from the National Institute of Allergy and Infectious Diseases to develop a prototype diagnostic for sepsis and community-acquired pneumonia, the company said today.

 

Under the five-year grant, Nanogen will collaborate with the Medical College of Wisconsin to provide an automated diagnostic system to rapidly detect bacteria and viruses that cause sepsis and pneumonia.

 

Mortality from sepsis ranges from 28 percent to 50 percent, according to the company, and pneumonia is the seventh leading cause of death in the US.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.